Clinical Trial Update: Pembrolizumab in Advanced/Metastatic Acral Lentiginous Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pembrolizumab in advanced/metastatic acral lentiginous melanoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acral Lentiginous Melanoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Acral Lentiginous Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2025-04-18